BPCE
NVO

Bank Pictet & Cie (Europe)’s Novo Nordisk NVO Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,228
Closed -$314K – 178
2017
Q1 		$314K Buy
+18,228
New +$317K 0.05% 166

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s NVO Position: Q2 2017 in Review

Bank Pictet & Cie (Europe) sold out of Novo Nordisk (NVO) in Q2 2017, closing a stake of 18,228 shares — an estimated $314K sold.

Bank Pictet & Cie (Europe) first reported a position in NVO in Q1 2017 and held it in 1 quarter. The position peaked at $314K in Q1 2017. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Bank Pictet & Cie (Europe) reported no remaining Novo Nordisk position as of Q2 2017 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 18,228 Novo Nordisk shares in Q2 2017, an estimated $314K.
  • Bank Pictet & Cie (Europe) first reported a position in Novo Nordisk in Q1 2017 and held it in 1 quarter.
  • Bank Pictet & Cie (Europe)'s Novo Nordisk position peaked at $314K in Q1 2017.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2017, filed 9 Aug 2017.